Health
Zimmer Biomet Holdings Is Only Temporarily Out of Joint
Focus on coronavirus patients has hospitals deferring elective surgeries, but eventually patients who need knee, hip and other replacements will be back on surgical schedules.
Jim Cramer: Here's the Science Behind Our Rally
While Johnson & Johnson and other pharma cos. give us hope, here's my wish list to keep the nation safe and the economy ready to go again.
Good Medicine for a Retest? Johnson & Johnson
A strong S&P for three days makes me leery of what's ahead, but here's an option in JNJ.
No Easy Fix for This Bumpy Ride in Market
In this environment, cutting rates is no quick solution, especially without a clear picture of coronavirus outbreak in U.S.
For Gym Rats, It's Garage Days Revisited
As the coronavirus causes worry about germs in the weight room, more people may exercise the option of working out at home with Peloton.
Jim Cramer: Hope for the Best, Plan for the Worst
Is this the end of the world? No. You still need to plan for your financial well-being, even as the CDC tells us 'this might be bad.'
Market Looks Past Apple Coronavirus Warnings
The indexes simply refuse to do the logical thing and pull back, which would help bears and bulls alike.
Jim Cramer: We're Getting Spun in a Crazy, Virtuous Circle
This market's bound by earnings and a virus, and both are astonishingly subjective.
Jim Cramer: China's Back On? Really?
At least days like today, when we're told the coronavirus has 'peaked,' show us exactly where the coiled springs really are.
Line Up This Trade With Align Technology
Here's how to play ALGN, which is expected to report later Wednesday, three weeks from its Feb. 21 expiration.